During the past decade, Hospital Dr. Gustavo Fricke conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Dr. Gustavo Fricke" #1 sponsor was "Universidad de Valparaiso" with 2 trials, followed by "Antisoma Research" with 1 trials sponsored, "Cogentus Pharmaceuticals" with 1 trials sponsored, "Edgardo Szyld" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Dr. Gustavo Fricke" #1 collaborator was "GlaxoSmithKline" with 2 trials as a collaborator, "Aclin Laboratory" with 1 trials as a collaborator, "Fundación Dr. Jorge Kaplan Meier" with 1 trials as a collaborator, "Hospital Dr. Gustavo Fricke" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Dr. Gustavo Fricke" are "Acute Coronary Syndrome" (1 trials), "COVID-19" (1 trials), "Cardiac Surgery" (1 trials), "Cardiovascular Diseases" (1 trials) and "Chronic Chagas Disease" (1 trials). Many other conditions were trialed in "Hospital Dr. Gustavo Fricke" in a lesser frequency.

Most popular intervention types in "Hospital Dr. Gustavo Fricke" are "Drug" (7 trials), "Biological" (2 trials), "Device" (2 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "40 mg Atorvastatin/day for 120 days P.O." (1 trials), "Amonafide and Cytarabine" (1 trials), "Atorvastatin 80" (1 trials) and "Belimumab 1 mg/kg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Dr. Gustavo Fricke" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Dr. Gustavo Fricke". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Hospital Dr. Gustavo Fricke, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Dr. Gustavo Fricke, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".